These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 17309825

  • 1. B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro.
    Lu ZY, Condomines M, Tarte K, Nadal L, Delteil MC, Rossi JF, Ferrand C, Klein B.
    Exp Hematol; 2007 Mar; 35(3):443-53. PubMed ID: 17309825
    [Abstract] [Full Text] [Related]

  • 2. Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells.
    Tarte K, Zhang XG, Legouffe E, Hertog C, Mehtali M, Rossi JF, Klein B.
    J Immunol; 1999 Jul 01; 163(1):514-24. PubMed ID: 10384156
    [Abstract] [Full Text] [Related]

  • 3. Preferential T cell expansion by artificial antigen presenting cells expressing 4-1BBL alone or in combination with CD80 or CD86.
    Habib-Agahi M, Jaberipour M, Phan TT, Searle PF.
    Iran J Immunol; 2008 Sep 01; 5(3):136-47. PubMed ID: 18791280
    [Abstract] [Full Text] [Related]

  • 4. Gene transfer of the costimulatory molecules B7-1 and B7-2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T cell response.
    Wendtner CM, Nolte A, Mangold E, Buhmann R, Maass G, Chiorini JA, Winnacker EL, Emmerich B, Kotin RM, Hallek M.
    Gene Ther; 1997 Jul 01; 4(7):726-35. PubMed ID: 9282174
    [Abstract] [Full Text] [Related]

  • 5. The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma.
    Xu DP, Sauter BV, Huang TG, Meseck M, Woo SL, Chen SH.
    Gene Ther; 2005 Oct 01; 12(20):1526-33. PubMed ID: 15973445
    [Abstract] [Full Text] [Related]

  • 6. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine.
    Guinn BA, DeBenedette MA, Watts TH, Berinstein NL.
    J Immunol; 1999 Apr 15; 162(8):5003-10. PubMed ID: 10202049
    [Abstract] [Full Text] [Related]

  • 7. Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myeloma.
    Wen XY, Mandelbaum S, Li ZH, Hitt M, Graham FL, Hawley TS, Hawley RG, Stewart AK.
    Cancer Gene Ther; 2001 May 15; 8(5):361-70. PubMed ID: 11477456
    [Abstract] [Full Text] [Related]

  • 8. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
    Qian J, Wang S, Yang J, Xie J, Lin P, Freeman ME, Yi Q.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8808-15. PubMed ID: 16361569
    [Abstract] [Full Text] [Related]

  • 9. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
    Mogi S, Ebata T, Setoguchi Y, Fujime M, Heike Y, Kohsaka T, Yagita H, Okumura K, Azuma M.
    Clin Cancer Res; 1998 Mar 15; 4(3):713-20. PubMed ID: 9533541
    [Abstract] [Full Text] [Related]

  • 10. Adoptively transferred tumor-specific T cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity in vivo.
    Yi KH, Nechushtan H, Bowers WJ, Walker GR, Zhang Y, Pham DG, Podack ER, Federoff HJ, Tolba KA, Rosenblatt JD.
    Cancer Res; 2007 Oct 15; 67(20):10027-37. PubMed ID: 17942937
    [Abstract] [Full Text] [Related]

  • 11. 4-1BBL enhances anti-tumor responses in the presence or absence of CD28 but CD28 is required for protective immunity against parental tumors.
    Guinn BA, Bertram EM, DeBenedette MA, Berinstein NL, Watts TH.
    Cell Immunol; 2001 May 25; 210(1):56-65. PubMed ID: 11485353
    [Abstract] [Full Text] [Related]

  • 12. Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse.
    Schendel DJ, Frankenberger B, Jantzer P, Cayeux S, Nöbetaner E, Willimsky G, Maget B, Pohla H, Blankenstein T.
    Gene Ther; 2000 Dec 25; 7(23):2007-14. PubMed ID: 11175312
    [Abstract] [Full Text] [Related]

  • 13. Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes.
    Grünebach F, Kayser K, Weck MM, Müller MR, Appel S, Brossart P.
    Cancer Gene Ther; 2005 Sep 25; 12(9):749-56. PubMed ID: 15877082
    [Abstract] [Full Text] [Related]

  • 14. Induction and large-scale expansion of CD8+ tumor specific cytotoxic T lymphocytes from peripheral blood lymphocytes by in vitro stimulation with CD80-transfected autologous melanoma cells.
    Mackensen A, Wittnebel S, Veelken H, Noppen C, Spagnoli GC, Lindermann A.
    Eur Cytokine Netw; 1999 Sep 25; 10(3):329-36. PubMed ID: 10477389
    [Abstract] [Full Text] [Related]

  • 15. 4-1BBL costimulation retrieves CD28 expression in activated T cells.
    Habib-Agahi M, Jaberipour M, Searle PF.
    Cell Immunol; 2009 Sep 25; 256(1-2):39-46. PubMed ID: 19217084
    [Abstract] [Full Text] [Related]

  • 16. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S, Wehler T, Schnürer E, Lennerz V, Brenner W, Melchior S, Gröne M, Nonn M, Strand S, Meyer R, Ranieri E, Huber C, Falk CS, Herr W.
    Cancer Res; 2006 Dec 01; 66(23):11447-54. PubMed ID: 17145892
    [Abstract] [Full Text] [Related]

  • 17. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
    Habib-Agahi M, Phan TT, Searle PF.
    Int Immunol; 2007 Dec 01; 19(12):1383-94. PubMed ID: 17977894
    [Abstract] [Full Text] [Related]

  • 18. Generation of potent antitumor CTL from patients with multiple myeloma directed against HM1.24.
    Rew SB, Peggs K, Sanjuan I, Pizzey AR, Koishihara Y, Kawai S, Kosaka M, Ozaki S, Chain B, Yong KL.
    Clin Cancer Res; 2005 May 01; 11(9):3377-84. PubMed ID: 15867238
    [Abstract] [Full Text] [Related]

  • 19. Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses.
    Bukczynski J, Wen T, Ellefsen K, Gauldie J, Watts TH.
    Proc Natl Acad Sci U S A; 2004 Feb 03; 101(5):1291-6. PubMed ID: 14745033
    [Abstract] [Full Text] [Related]

  • 20. B7.1 expression on tumor cells circumvents the need of professional antigen presentation for in vitro propagation of cytotoxic T cell lines.
    Iezzi G, Protti MP, Rugarli C, Bellone M.
    Cancer Res; 1996 Jan 01; 56(1):11-5. PubMed ID: 8548749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.